Mind Medicine Inc (MNMD NASDAQ) stock market data APIs
$7.18
0.19(2.7%)
as of January 24, 2025
Mind Medicine Inc Financial Data Overview
Price chart is built with
Anychart
Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.
Prev. Close
6.99
Open
7.18
Volume
757 K
High
7.3
Low
6.95
52 wk Range
3.67-12.22
Market Cap
513 M
Shares Outstanding
73 332 K
Revenue
0
EPS
-0.27
Beta
2.332
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Mind Medicine Inc data using free add-ons & libraries
Get Mind Medicine Inc Fundamental Data
Mind Medicine Inc Fundamental data includes:
- Net Revenue: 0
- EBITDA: -80 931 000
- Earnings Per Share: -1
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-11-07
- EPS/Forecast: -0.28
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mind Medicine Inc News
New
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
Key Takeaways; Cannabis Sector Ascend Wellness reported Q2 revenue growth amid rising competition and profit decline. Green Thumb Industries surpassed Q2 expectations with 11% revenue growth. Truliev...
FDA Favorites: 3 Biotech Stocks on the Verge of Major Approvals
The biotech industry has fallen on hard times over the last few years, no thanks to venture capital drying up, tighter regulatory conditions and the harsh reality of the post-pandemic healthcare envir...
Street calls of the week: Upgrades for Dupont, Datadog and NetApp
Investing.com -- Here is your Pro Recap of the top takeaways from Wall Street analysts for the past week: upgrades for Dupont, Datadog and NetApp. InvestingPro subscribers always get first dibs on ma...
Jim Cramer’s Latest Stock Picks in May 2024
Jim Cramer on Friday analyzed the market rally following the latest CPI data which showed inflation was easing in April. Cramer said bears are clearly fighting an "uphill" battle and unless they could...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
